Related Experiment Video
Updated: Jun 18, 2026

09:44
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
ACS Medicinal Chemistry Letters
|June 17, 2026
Summary
New brain stimulation and drug discovery methods aim to enhance neuroplasticity for treating psychiatric disorders. This research integrates molecular, cellular, and physiological approaches for precise therapeutic outcomes without perceptual side effects.
Area of Science:
- Neuroscience
- Pharmacology
- Biomedical Engineering
Background:
- Current psychiatric treatments often cause side effects.
- There is a need for therapies that promote neuroplasticity without altering perception.
- Advances in molecular and neuromodulation techniques offer new possibilities.
Related Concept Videos
Neuroplasticity
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...

